Overview

Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of nebivolol and valsartan given as a free tablet combination in patient with stage 1 or stage 2 essential hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Forest Laboratories
Treatments:
Hydrochlorothiazide
Nebivolol
Valsartan